Upstream Bio (UPB) Other Accumulated Expenses (2024 - 2025)
Upstream Bio's (UPB) quarterly Other Accumulated Expenses came in at $55000.0 in Q3 2025, down 53.39% year-on-year from $118000.0 in Q3 2024, and down 53.39% quarter-over-quarter from $118000.0 in Q3 2024.
Upstream Bio (UPB) Other Accumulated Expenses (2024 - 2025) Analysis & Trends
Upstream Bio's Other Accumulated Expenses history runs 2 years deep, the most recent figure standing at $55000.0 for Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Upstream Bio | 347.73 Mn | 347.73 Mn | -3.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 55,000.00 |
| Sep 30, 2024 | 118,000.00 |